Cargando…
Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The African Field Epidemiology Network
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847221/ https://www.ncbi.nlm.nih.gov/pubmed/33552361 http://dx.doi.org/10.11604/pamj.2020.37.243.25512 |
| _version_ | 1783644889319211008 |
|---|---|
| author | Wilson, Herieth Ismael Mapesi, Herry |
| author_facet | Wilson, Herieth Ismael Mapesi, Herry |
| author_sort | Wilson, Herieth Ismael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7847221 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The African Field Epidemiology Network |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78472212021-02-05 Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications Wilson, Herieth Ismael Mapesi, Herry Pan Afr Med J Letter to the Editors The African Field Epidemiology Network 2020-11-17 /pmc/articles/PMC7847221/ /pubmed/33552361 http://dx.doi.org/10.11604/pamj.2020.37.243.25512 Text en Copyright: Herieth Ismael Wilson et al. https://creativecommons.org/licenses/by/4.0 The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editors Wilson, Herieth Ismael Mapesi, Herry Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications |
| title | Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications |
| title_full | Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications |
| title_fullStr | Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications |
| title_full_unstemmed | Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications |
| title_short | Rollout of dolutegravir-based antiretroviral therapy in sub-Saharan Africa and its public health implications |
| title_sort | rollout of dolutegravir-based antiretroviral therapy in sub-saharan africa and its public health implications |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847221/ https://www.ncbi.nlm.nih.gov/pubmed/33552361 http://dx.doi.org/10.11604/pamj.2020.37.243.25512 |
| work_keys_str_mv | AT wilsonheriethismael rolloutofdolutegravirbasedantiretroviraltherapyinsubsaharanafricaanditspublichealthimplications AT mapesiherry rolloutofdolutegravirbasedantiretroviraltherapyinsubsaharanafricaanditspublichealthimplications |